Imbruvica 140mg 90 Capsules

Imbruvica 150 mg is an anticancer medication classified as a Bruton’s tyrosine kinase (BTK) inhibitor. It is used to treat certain types of blood cancers, including chronic lymphocytic leukemia, mantle cell lymphoma, and follicular lymphoma.

Indications:

• Chronic lymphocytic leukemia (CLL)

• Follicular lymphoma

• Mantle cell lymphoma (MCL)

• Epstein-Barr virus–associated lymphoproliferative disorders

Dosage & Administration:

• As prescribed by the treating physician.

• Taken orally with a glass of water.

• Capsules should not be crushed or chewed.

Warnings & Precautions:

• For use only under the supervision of a healthcare professional.

• Inform the doctor of any liver or heart problems.

• May increase the risk of bleeding or infections.

• Avoid consuming grapefruit or grapefruit juice during treatment.

Common Side Effects:

• Diarrhea

• Fatigue

• Muscle pain

• Rash

• Dizziness or headache